Janus Henderson Group PLC Geron Corp Transaction History

Janus Henderson Group PLC

$194 Billion
Q2 2025

A detailed history of Janus Henderson Group PLC transactions in Geron Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 239,357 shares of GERN stock, worth $323,131. This represents 0.0% of its overall portfolio holdings.

Number of Shares

239,357

Previous 18,892,975 98.73%

Holding current value

$323,131

Previous $30 Million 98.88%

% of portfolio

0.0%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$1.18 - $1.62 $22 Million - $30.2 Million	-18,653,618 Reduced 98.73%	239,357 $337,000
Q1 2025 May 15, 2025	SELL	$1.59 - $3.6 $13 Million - $29.5 Million	-8,189,486 Reduced 30.24%	18,892,975 $30 Million
Q4 2024 Feb 14, 2025	BUY	$3.3 - $4.44 $14.9 Million - $20.1 Million	4,516,615 Added 20.02%	27,082,461 $95.9 Million
Q3 2024 Nov 14, 2024	BUY	$4.17 - $4.99 $54.9 Million - $65.7 Million	13,163,889 Added 140.01%	22,565,846 $102 Million
Q2 2024 Aug 14, 2024	BUY	$3.1 - $5.09 $28.6 Million - $46.9 Million	9,220,920 Added 5093.39%	9,401,957 $39.9 Million
Q1 2024 May 15, 2024	BUY	$1.75 - $3.44 $33 - $65	19 Added 0.01%	181,037 $597,000
Q4 2023 Feb 14, 2024	SELL	$1.74 - $2.31 $508 - $674	-292 Reduced 0.16%	181,018 $381,000
Q3 2023 Nov 14, 2023	BUY	$2.11 - $3.28 $105 - $164	50 Added 0.03%	181,310 $384,000
Q2 2023 Aug 14, 2023	SELL	$1.97 - $3.69 $433 - $811	-220 Reduced 0.12%	181,260 $581,000
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $282,614 - $449,014	132,063 Added 267.24%	181,480 $393,000
Q4 2022 Feb 14, 2023	SELL	$2.03 - $2.42 $36 - $43	-18 Reduced 0.04%	49,417 $119,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $313 - $552	188 Added 0.38%	49,435 $116,000
Q2 2022 Aug 15, 2022	BUY	$1.19 - $1.65 $239 - $331	201 Added 0.41%	49,247 $76,000
Q1 2022 May 16, 2022	BUY	$0.99 - $1.6 $20 - $33	21 Added 0.04%	49,046 $67,000
Q4 2021 Feb 14, 2022	BUY	$1.22 - $1.72 $30,184 - $42,554	24,741 Added 101.88%	49,025 $60,000
Q3 2021 Nov 16, 2021	BUY	$1.2 - $1.5 $29,140 - $36,426	24,284 New	24,284 $33,000

Others Institutions Holding GERN

# of Institutions

281

Shares Held

509M

Call Options Held

885K

Put Options Held

564K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $510M
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Geron Corp Transaction History